Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTA) Payables (2019 - 2025)

Strata Critical Medical (SRTA) has disclosed Payables for 7 consecutive years, with $19.1 million as the latest value for Q4 2025.

  • Quarterly Payables rose 107.61% to $19.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $19.1 million through Dec 2025, up 107.61% year-over-year, with the annual reading at $19.1 million for FY2025, 107.61% up from the prior year.
  • Payables for Q4 2025 was $19.1 million at Strata Critical Medical, down from $27.2 million in the prior quarter.
  • The five-year high for Payables was $27.2 million in Q3 2025, with the low at $1.3 million in Q1 2021.
  • Average Payables over 5 years is $12.7 million, with a median of $11.5 million recorded in 2022.
  • The sharpest move saw Payables skyrocketed 4858.0% in 2021, then crashed 61.36% in 2024.
  • Over 5 years, Payables stood at $6.4 million in 2021, then surged by 159.63% to $16.5 million in 2022, then surged by 44.29% to $23.9 million in 2023, then plummeted by 61.36% to $9.2 million in 2024, then skyrocketed by 107.61% to $19.1 million in 2025.
  • According to Business Quant data, Payables over the past three periods came in at $19.1 million, $27.2 million, and $13.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.